Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

Ellen M. Apperloo, Brendon L. Neuen, Robert A. Fletcher, Niels Jongs, Stefan D. Anker, Deepak L. Bhatt, Javed Butler, David Z.I. Cherney, William G. Herrington, Silvio E. Inzucchi, Meg Jardine, Chih‐Chin Liu, Kenneth W. Mahaffey, Darren K. McGuire, John J.V. McMurray, Bruce Neal, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Natalie Staplin, Michael Szarek, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faïez Zannad, Hiddo J.L. Heerspink